Loading...
OTCMYKLTY
Market cap5.79bUSD
Dec 26, Last price  
9.60USD
1D
5.19%
1Q
-15.57%
Name

Yakult Honsha Co Ltd

Chart & Performance

D1W1MN
OTCM:YKLTY chart
P/E
9.00
P/S
0.91
EPS
168.22
Div Yield, %
535.80%
Shrs. gr., 5y
-0.67%
Rev. gr., 5y
4.33%
Revenues
503.08b
+4.14%
247,506,000,000267,707,000,000273,099,000,000317,335,000,000293,490,000,000290,678,000,000305,944,000,000312,552,000,000319,193,000,000350,322,000,000367,980,000,000390,412,000,000378,307,000,000401,569,000,000407,017,000,000406,004,000,000385,706,000,000415,116,000,000483,071,000,000503,079,000,000
Net income
51.01b
+0.72%
14,104,000,00014,442,000,00014,805,000,00016,675,000,00011,324,000,00013,248,000,00013,168,000,00013,291,000,00016,379,000,00022,543,000,00025,056,000,00028,843,000,00030,154,000,00034,064,000,00034,935,000,00039,735,000,00039,267,000,00044,917,000,00050,641,000,00051,006,000,000
CFO
70.70b
-18.28%
19,348,000,00026,919,000,00025,724,000,00025,177,000,00037,559,000,00039,535,000,00040,987,000,00033,444,000,00042,887,000,00048,579,000,00055,407,000,00062,149,000,00059,998,000,00061,989,000,00062,125,000,00062,791,000,00055,820,000,00073,390,000,00086,513,000,00070,702,000,000
Dividend
Sep 28, 20230.1262 USD/sh
Earnings
Feb 07, 2025

Profile

Yakult Honsha Co.,Ltd. manufactures and sells food and beverage products, cosmetics, pharmaceuticals, and others. It operates through Food and Beverages (Japan), Food and Beverages (The Americas), Food and Beverages (Asia and Oceania), Food and Beverages (Europe), Pharmaceuticals, and Others segments. The company offers fermented milk drinks, juices, noodles, etc. through its home delivery and retail store channels. It also provides pharmaceutical products, such as Elplat, an antineoplastic drug, as well as generic anti-cancer agents, including Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. In addition, the company offers cosmetics; and operates the Tokyo Yakult Swallows, a professional baseball team. Yakult Honsha Co.,Ltd. was founded in 1935 and is headquartered in Tokyo, Japan.
URL
https://www.yakult.co.jp/
IPO date
Jan 23, 1980
Employees
29,880
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
503,079,000
4.14%
483,071,000
16.37%
415,116,000
7.62%
Cost of revenue
439,679,000
426,383,000
370,567,000
Unusual Expense (Income)
NOPBT
63,400,000
56,688,000
44,549,000
NOPBT Margin
12.60%
11.73%
10.73%
Operating Taxes
22,528,000
22,636,000
20,197,000
Tax Rate
35.53%
39.93%
45.34%
NOPAT
40,872,000
34,052,000
24,352,000
Net income
51,006,000
0.72%
50,641,000
12.74%
44,917,000
14.39%
Dividends
(15,588,000)
(12,712,000)
(9,934,000)
Dividend yield
1.61%
0.42%
0.48%
Proceeds from repurchase of equity
(29,379,000)
(17,208,000)
(29,753,000)
BB yield
3.04%
0.57%
1.42%
Debt
Debt current
57,985,000
54,743,000
15,892,000
Long-term debt
50,187,000
33,489,000
77,153,000
Deferred revenue
5,000
6,332,000
6,299,000
Other long-term liabilities
10,388,000
3,017,000
2,869,000
Net debt
(312,784,000)
(313,432,000)
(261,987,000)
Cash flow
Cash from operating activities
70,702,000
86,513,000
73,390,000
CAPEX
(46,233,000)
(30,285,000)
(26,725,000)
Cash from investing activities
(43,906,000)
(19,024,000)
(11,875,000)
Cash from financing activities
(39,541,000)
(44,531,000)
(45,156,000)
FCF
(10,570,000)
24,046,000
16,420,000
Balance
Cash
255,257,000
241,185,000
202,941,000
Long term investments
165,699,000
160,479,000
152,091,000
Excess cash
395,802,050
377,510,450
334,276,200
Stockholders' equity
675,089,000
1,060,854,000
962,383,000
Invested Capital
316,738,950
242,932,550
238,440,800
ROIC
14.61%
14.15%
10.39%
ROCE
8.51%
8.79%
7.49%
EV
Common stock shares outstanding
310,032
312,428
320,432
Price
3,119.00
-67.61%
9,630.00
47.70%
6,520.00
16.43%
Market cap
966,989,808
-67.86%
3,008,681,640
44.01%
2,089,216,640
16.31%
EV
710,866,808
3,217,091,640
2,320,265,640
EBITDA
91,241,000
82,021,000
68,318,000
EV/EBITDA
7.79
39.22
33.96
Interest
660,000
666,000
680,000
Interest/NOPBT
1.04%
1.17%
1.53%